REMOGLIFLOZIN: INDIA IS THE FIRST COUNTRY TO GET ACCESS TO AN INNOVATIVE TYPE-2 DIABETES DRUG
Remogliflozin was discovered and developed by Japanese firm Kissei Pharmaceutical Co and subsequently developed by GlaxoSmithKline Plc and BHV Pharma, a…
Remogliflozin was discovered and developed by Japanese firm Kissei Pharmaceutical Co and subsequently developed by GlaxoSmithKline Plc and BHV Pharma, a…